This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Asclepius Pharmaceutical, LLC. Active years: 2024-2025.
Company Filing History:
1 out of 1 Years Active: 2024-2025
Title: Michael Mullan: Innovator in Pharmaceutical Composition
Introduction
Michael Mullan is a notable inventor based in Sarasota, Florida. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patent.
Latest Patents
Mullan holds a patent for a pharmaceutical composition. This composition comprises a therapeutically effective amount of at least one alkaloid combined with one or more non-alkaloid components. The composition is specifically configured to be administered to a subject, showcasing Mullan's commitment to advancing medical treatments.
Career Highlights
Mullan is associated with The Roskamp Institute, where he contributes to research and development in the pharmaceutical sector. His work focuses on creating effective therapeutic solutions that can improve patient outcomes.
Collaborations
Mullan collaborates with esteemed colleagues such as Gary Kompothecras and Daniel Paris. Their combined expertise enhances the research efforts at The Roskamp Institute.
Conclusion
Michael Mullan's innovative work in pharmaceutical compositions exemplifies his dedication to improving healthcare through scientific advancements. His contributions are vital in the ongoing quest for effective medical treatments.